The First Postpartum Depression Pill Is Now Available in the U.S., but It Costs Nearly $16K Before...

Published on 16 Dec 2023 on NowThis

The FDA approved Zurzuvae in August 2023 . According to pharmaceutical companies Biogen Inc. and ...

Read the rest of the article

Start tracking your investments with Statfolio

Shares of Sage Pharmaceuticals SAGE dropped 19.6% on Wednesday after management shared topline re...

Zacks via Yahoo Finance 19 Apr 2024

Sage Therapeutics, Inc. (SAGE) is expected to deliver a year-over-year increase in earnings on hi...

Zacks via Yahoo Finance 19 Apr 2024

Sage Therapeutics Inc. has decided to halt work on an experimental drugs in Parkinson’s disease...

The Business Journals 18 Apr 2024

Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Dat...

Benzinga via Yahoo Finance 17 Apr 2024

Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge

Investing.com 17 Apr 2024

Sage Therapeutics shares dropped early Wednesday after the company said its experimental treatmen...

Market Watch 17 Apr 2024

Sage Therapeutics (SAGE) stock plummeted after the company's Phase 2 trial for Parkinson’s diseas...

Seeking Alpha 17 Apr 2024

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company, disclosed today that its Pha...

Investing.com 17 Apr 2024

In this piece, we will take a look at the 12 best all time low stocks to invest in. If you want t...

Insider Monkey via Yahoo Finance 11 Apr 2024

A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares hav...

Zacks via Yahoo Finance 15 Mar 2024